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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A149differentiation and peaked during early chondrogenic differentiation
(day 5), after which viperin levels gradually decreased until day 14
(comparable to day 4 expression). To investigate with which chon-
drocyte phenotype viperin expression is primarily associated (chon-
drogenic or hypertrophic), its expression was assessed in the
presence or absence of hypertrophic inducer BMP-2 or hypertrophic
suppressor BMP-7. Viperin gene expression was greatly induced by
exposure of ATDC5 cells to BMP-2, while BMP-7 suppressed viperin
expression, indicating a positive association between viperin and the
level of chondrocyte hypertrophy. Viperin functionality during ATDC5
chondrogenic differentiation was investigated by interfering with
viperin expression using RNAi. Viperin expression was targeted from
day 3 in differentiation onward and the cells were analyzed at day 7.
KD of viperin resulted in 90% reduced expression of Col2a1 mRNA at
day 7 in differentiation. Interestingly, gene expression of the hyper-
trophic markers Mef2c and Col10a1 was not inﬂuenced (Figure 1A).
As the viperin protein is located in the ER, the main location for
protein secretion, and chondrogenic differentiation requires vast
amounts of extracellular matrix synthesis and protein secretion, we
explored a possible link between viperin and protein secretion. KD of
viperin resulted in reduced protein secretion and an increased gene
expression of Chop, a commonly used marker for ER stress (Figure 1
A/B).
Conclusions: Overall, our data show that viperin is expressed in
several stages of chondrocyte development and that its expression
may be regulated via hypertrophic extracellular cues. KD of viperin
speciﬁcally induced Chop levels and abrogated the expression of
Col2a1 mRNA, while leaving Col10a1 mRNA expression unaffected.
This suggests that viperin KD induces ER stress and skews the
chondrocyte phenotype towards hypertrophy. Moreover, the link
between viperin and protein secretion in chondrocytes suggest that
mutations in the RMRP gene may lead to the CHH-associated
dwarﬁsm via abnormal protein-secretory processes. In our ongoing
research we are deﬁning the link between viperin, ER stress and
chondrocyte hypertrophy, and investigating the role of viperin in
chondrocyte protein secretion / extracellular matrix synthesis. Our
data are the ﬁrst to implicate the antiviral protein viperin as a
chondrogenic regulator.
Figure 1. A) KD of viperin expression by RNAi results in a 90% reduction
of Col2a1 gene expression at day 7 in ATDC5 chondrogenic differ-
entiation. Expression of the hypertrophic markers Col10a1 and Mef2c
was not affected; skewing cells towards hypertrophy. KD of viperin also
results in increased ER stress indicated by increased expression of
Chop. B) Moreover, viperin KD resulted in 32% reduced protein secre-
tion (ATDC5 d4).
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FUNCTION OF THE CHONDROCYTE PI-3 KINASE-AKT SIGNALING
PATHWAY IS STIMULUS DEPENDENT
M.A. Greene y,z, R.F. Loeser z. yWake Forest Univ. Sch. of Med., Winston-
Salem, NC, USA; z The Univ. of North Carolina at Chapel Hill, Chapel Hill,
NC, USA
Purpose: The PI-3 kinase-Akt pathway plays a role in cartilage
anabolic and catabolic processes in response to activation by insulin-
like growth factor-1 (IGF-1) and the pro-inﬂammatory cytokines
interleukin-1b (IL-1b) and oncostatin M (OSM). IGF-1 promotes
proteoglycan and collagen II synthesis while IL-1b and OSM promoteincreased MMP production and matrix degradation. These stimuli
share activation of the PI-3 kinase-Akt pathway, which has led some
groups to suggest that inhibition of this pathway would be an
effective therapeutic target in the treatment of OA. The goal of this
study was to determine how PI-3 kinase-Akt signaling regulates
these seemingly opposing functions.
Methods: Human articular chondrocytes were isolated from normal
human ankle (talar) and knee cartilage. Primary conﬂuent monolayer
cultures were serum-starved overnight before treatment with IGF-1
(100ng/mL), IL-1b (10ng/mL), OSM (10ng/mL), or IL-1bþOSM (10ng/
mLþ10ng/mL). In experiments with chemical inhibitors, cells were pre-
treated with the inhibitor or DMSO vehicle for 30min before treatment
with IGF-1, IL-1b, OSM, or IL-1bþOSM. Activation of signaling proteins
was measured by immunoblotting of the total cell lysate with phospho-
speciﬁc antibodies. MMP-13 production was measured by immuno-
blotting of the conditioned media and ELISA. Constitutively active Akt1
and Akt3 were expressed by lentiviral transduction and plasmid
nucleofection, respectively, to study stimulus-independent activation of
Akt.
Results: In time course experiments (0-60min), IGF-1, OSM, and the
combination of IL-1b and OSM but not IL-1b alone, stimulated
phosphorylation of Akt which was sustained longer with IGF-1 (Fig
1). IL-1bþOSM, but not IGF-1, increased chondrocyte MMP-13 pro-
duction which was inhibited with either a general PI-3 kinase
inhibitor (p¼0.0176) or speciﬁc inhibition of the PI-3 kinase-g iso-
form (p¼0.0358). Over-expression of constitutively active Akt1 or
Akt3 was not sufﬁcient to increase production of MMP-13 either in
un-stimulated cells or cells treated with the combination of IL-1b
and OSM. Inhibition of the ERK, JNK, and p38 MAP kinase pathways
as well as the JAK/STAT pathway signiﬁcantly inhibited the IL-
1bþOSM mediated MMP-13 production (densitometric analysis from
3 independent donors: p<0.0001 for all inhibitors, Fig 2). The JNK,
p38, and JAK/STAT pathways were activated by IL-1bþOSM but not
by IGF-1 (Fig 1). Additionally, inhibition of the JAK/STAT pathway
blocked IL-1b/OSM mediated p-Akt but had no effect on IGF-1
mediated p-Akt.
Conclusions: The chondrocyte integrates signals from the PI-3 kinase-
Akt pathway with signals from MAP kinases and the JAK-STAT pathway
to allow for a differential response to a pro-anabolic (IGF-1) and a pro-
catabolic (IL-1bþOSM) stimulus. Due to the ability of the JAK/STAT
inhibitor to block IL-1bþOSM mediated p-Akt and MMP-13 without
blocking IGF-1 mediated p-Akt, we suggest the JAK/STAT pathway as a
more effective therapeutic target in the treatment of OA than the PI-3
kinase-Akt pathway.Figure 1. Primary human chondrocytes were treated with IGF-1, IL-1b,
OSM, or IL-1b/OSM over a time course from 0-60min. Total cell lysates
were immunoblotted with phospho-speciﬁc antibodies. Total protein
blots are shown as loading controls.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A150Figure 2. Primary human chondrocytes were pre-treated with inhibitors
for 30min and then treated with IL-1b/OSM overnight. Conditioned media
was immunoblotted for MMP-13. MMP-2 is shown as a loading control.
Experiment was repeated in 3 normal donors. Representative blots are
shown. PD98059: ERK inh. SP600125: JNK inh. SB203580: p38 inh. Rux-
olitinib: JAK1/2 inh.
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REDOX REGULATION OF CHONDROCYTE IGF-1 SIGNALING BY PKC-b1
V. Ulici y, D. Long z, R.F. Loeser, Jr. y. yUNC at Chapel Hill, Chapel Hill, NC,
USA; zWake Forrest Univ., Winston Salem, NC, USA
Purpose: Reactive oxygen species (ROS) can contribute to articular
cartilage degeneration in OA, but the mechanisms are incompletely
understood. IGF-1 signaling promotes chondrocyte matrix synthesis
and survival but is reduced in aging and OA. We have previously shown
that pathological levels of ROS activate chondrocyte MAP kinase sig-
naling and inhibit the IGF-1-IRS-1-PI3K-Akt pathway through phos-
phorylation of IRS-1 at inhibitory serine residues. In other tissues, PKC-
b1 activation by ROS was noted to serine phosphorylate IRS-1. In this
study, we investigated the role of PKC-b1 oxidation in regulating
chondrocyte IGF1 signaling under conditions of oxidative stress.
Methods: Primary human articular chondrocytes, isolated from normal
adult ankles, were treated for 30 mins. with 250mM tert-butyl hydro-
peroxide (tBHP) or 25mM menadione to induce oxidative stress. A PKC
general activator (PMA) and inhibitor (BIM) as well as a PKC-b speciﬁc
inhibitor (hispidin) were used to evaluate PKC regulation of IRS-1, ERK
MAP kinase and Akt phosphorylation, measured by immunoblotting.
PKC activation was measured by examining translocation from the
cytosol to the membrane by immunoblotting fractionated cell lysates.
PKC-b1 oxidation was evaluated by measuring cysteine sulfenic acid
formation using the reagent BCN-Bio1 which has a biotin tag allowing
for afﬁnity puriﬁcation of labelled proteins using streptavidin agarose
beads.
Results: Treatment of chondrocytes with PMA resulted in complete
inhibition of IGF1-induced phosphorylation of IRS-1 Tyr 612 (activating
site) as well as Akt phosphorylation and increased ERK and IRS-1 Ser
312 (inhibitory site) phosphorylation. The general PKC inhibitor BIM
blocked these effects conﬁrming they were due to PKC activation. ROS
induction using tBHP or menadione also activated ERK and decreased
IGF1 -induced IRS-1 Tyr 612 and p-Akt which was blocked by addition
of a PKC-b inhibitor. PKC-b1 translocated from the cytosol to the
membrane after treatment with menadione consistent with activation
by ROS (Fig.1A). A major mechanism for redox regulation of kinase
activity is through cysteine sulfenylation. We investigated this in
chondrocytes treated with menadione by afﬁnity labeling with BCN-
Bio1 which is speciﬁc for sulfenylation. PKC-b1 was pulled-down by
streptavidinwith the greatest amount seen after 30 mins. of menadione
treatment (Fig.1B).
Conclusions: These results support a role for PKC-b1 in the inhibition of
chondrocyte IGF-1 signaling under conditions of oxidative stress. Con-
sistent with our results, oxidation of PKC isoforms through cysteine
sulfenylation has been shown to promote their activity. Speciﬁc PKCs,
including PKC-b1, can serine phosphorylate IRS-1 resulting in inhibition
of downstream activation of Akt. Targeting the oxidative modiﬁcations
of PKC-b1 could serve as a novel means to restore the chondrocyte
response to IGF-1 in aging and OA.Fig.1. Oxidation of PKC-b1 in human chondrocytes treated with mena-
dione. (A) PKC-b1 translocation from the cytosol to the membrane. IGF-
1Rb (membrane) and LDH (cytosol) serve as fractionation controls. (B)
Pull-down of BCN-Bio1 tagged PKC-b1 using streptavidin. Levels of PKC-
b1 in the pre-pull down lysates shown as a control.
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SUPERFICIAL ZONE CHONDROCYTES SECRETE A FACTOR THAT
REGULATES DEEP ZONE CARTILAGE MINERALIZATION BY
MODULATING POLYPHOSPHATE LEVELS
E. Delve, S. Bromand, J.-P. St-Pierre, M. Grynpas, R. Kandel. The
Lunenfeld-Tanenbaum Res. Inst., Toronto, ON, Canada
Purpose: Articular cartilage is an avascular tissue with a complex
depth-dependent zonal architecture with unique matrix composition
and organization, vital for maintaining joint function. Osteoarthritis
(OA) is a degenerative disease that disrupts this zonal arrangement and
manifests initially as loss of the superﬁcial zone (SZ) followed by pro-
gressive matrix loss and advancement of the calciﬁed zone into the
remaining articular cartilage region. We have shown previously that
polyphosphate, a naturally occurring linear polymer of phosphates, can
regulate mineralization in articular cartilage. The hypothesis of this
study is that superﬁcial zone cells modulate calciﬁcation of deep zone
cartilage (DZ) by modulating levels of cartilage polyphosphate levels
through a soluble factor.
Methods: Articular chondrocytes were isolated from either the SZ or DZ
of bovine cartilage obtained from the metacarpal-phalangeal joints (6-9
months). The cells were seeded individually on 3Dmembrane inserts in
conditions that favour formation of cartilage tissue and grown in side-
by-side co-culture for up to 7 days in mineralization inducing media
(MIM, b glycerophosphate). As a control DZ cells were grown in co-
culture with DZ cells. To determine if SZ cells were producing a soluble
